| Followers | 1312 |
| Posts | 128332 |
| Boards Moderated | 1 |
| Alias Born | 08/28/2009 |
Thursday, May 13, 2021 4:17:53 PM
news is good, back to $10 in a few weeks
My opinions and comments are exactly that. They are not a recommendation to either buy or sell any security.
Recent PALI News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/17/2026 08:30:34 PM
- Palisade Bio Announces Abstract Selected for Poster Presentation at Digestive Disease Week (DDW) 2026 • GlobeNewswire Inc. • 04/16/2026 12:50:00 PM
- Palisade Bio to Present at the Needham & Co. 25th Annual Healthcare Conference • GlobeNewswire Inc. • 04/08/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:34:41 PM
- Palisade Bio Reports Positive Topline Data from Phase 1b Clinical Study of PALI-2108 in Fibrostenotic Crohn’s Disease • GlobeNewswire Inc. • 03/30/2026 08:01:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/20/2026 08:22:38 PM
- Palisade Bio Announces Participation in Two Upcoming Investor Conferences • GlobeNewswire Inc. • 03/02/2026 02:00:00 PM
- Palisade Bio Reports Rapid Clinical, Histologic and New Mechanistic Colon Tissue RNA Sequencing Data Supporting Targeted Activity of PALI-2108 at ECCO 2026 • GlobeNewswire Inc. • 02/23/2026 01:40:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 09:28:30 PM
- Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board • GlobeNewswire Inc. • 02/17/2026 01:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2026 01:10:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 10:34:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 10:32:05 PM
- Palisade Bio to Participate in the Piper Sandler Virtual Novel Targets in Immunology Symposium • GlobeNewswire Inc. • 02/09/2026 02:00:00 PM
- Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/05/2026 01:45:00 PM
- Palisade Bio Appoints Leading Global IBD Experts, Laurent Peyrin-Biroulet, MD, PhD and David T. Rubin, MD, to Its Clinical Advisory Board • GlobeNewswire Inc. • 01/29/2026 01:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 09:05:24 PM
- Palisade Bio Announces Two Abstracts Selected for Poster Presentations at Leading Global Inflammatory Bowel Disease Conferences • GlobeNewswire Inc. • 01/16/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 02:43:07 AM
- Palisade Bio Announces Strategic Equity Investment from the Crohn’s & Colitis Foundation’s IBD Ventures Program to Advance PALI-2108 • GlobeNewswire Inc. • 01/07/2026 01:15:00 PM
- Palisade Bio Announces Granting of Japanese Patent Covering Composition of Matter for Lead Product Candidate, PALI-2108 • GlobeNewswire Inc. • 12/30/2025 01:35:00 PM
